Home
Conditions
Multiple Myeloma and Plasma Cell Neoplasm

Clinical trial condition

Multiple Myeloma and Plasma Cell Neoplasm

Explore clinical trials studying Multiple Myeloma and Plasma Cell Neoplasm. Study availability and eligibility vary by location and protocol.

214 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma and Plasma Cell Neoplasm trial results

Completed

Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma

NCT00006232

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Birmingham Heartlands Hospital Birmingham, England, United Kingdom

Addenbrooke's Hospital at Cambridge University Hospitals NHS Foundation Trust Cambridge, England, United Kingdom

Royal Liverpool and Broadgreen Hospitals NHS Trust Liverpool, England, United Kingdom

New Cross Hospital Wolverhampton, England, United Kingdom

View Trial Details

Completed

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Primary Systemic Amyloidosis

NCT00564889

Conditions: Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +18 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

NCT00060255

Conditions: Amyloidosis, Blast Crisis, Blood Protein Disorders, +84 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

NCT00258245

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma

NCT00002552

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +39 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

NCT00002907

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

NCT00521430

Conditions: Anemia, Anemia, Aplastic, Anemia, Refractory, +76 more
Locations: Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea

View Trial Details

Completed

Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer

NCT00003408

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +122 more
Locations: Midwestern Regional Medical Center Zion, Illinois, United States

View Trial Details

Completed

Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer

NCT00002742

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +24 more
Locations: Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States

Holt-Krock Clinic Fort Smith, Arkansas, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

Office of Rosalda Rodriguez, M.D. Chula Vista, California, United States

View all 59 locations

View Trial Details

Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

NCT00003406

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations: Midwestern Regional Medical Center Zion, Illinois, United States

View Trial Details

Multiple Myeloma and Plasma Cell Neoplasm

Multiple Myeloma and Plasma Cell Neoplasm trial results

Related conditions